SciSparc CTO updates share and option details

SciSparc Ltd. reports updated equity holdings for Chief Technology Officer Adi Zuloff-Shani in an amendment to an earlier ownership statement.

Rhea-AI Filing Summary

SciSparc Ltd. reports updated equity holdings for Chief Technology Officer Adi Zuloff-Shani in an amendment to an earlier ownership statement. The amendment clarifies that the reported position represents 5,528 Ordinary Shares issuable upon the vesting of restricted share units, split between 5,000 RSUs vesting in quarterly installments of 625 shares through December 18, 2027 and 528 RSUs vesting in quarterly installments of 66 shares through June 20, 2026. It also restates option data, confirming a stock option covering 6 Ordinary Shares at an exercise price of 31941.0000, expiring January 3, 2028.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Zuloff-Shani Adi

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Stock option (right to buy) F2	--	--	--
holding	Ordinary Shares F1	--	--	--

Holdings After Transaction: Stock option (right to buy) — 6 contracts (Direct); Ordinary Shares — 5,528 shares (Direct)

Footnotes (2)

1. F1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends and restates the first footnote in Table I as follows: "Includes (i) 5,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 625 Ordinary Shares through December 18, 2027; and (ii) 528 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 66 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." In addition, this amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
2. F2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

Key Figures

Ordinary Shares tied to RSUs: 5,528 Ordinary Shares Primary RSU grant: 5,000 Ordinary Shares Secondary RSU grant: 528 Ordinary Shares +5 more

8 metrics

Ordinary Shares tied to RSUs 5,528 Ordinary Shares Total Ordinary Shares issuable upon RSU vesting reported for the CTO

Primary RSU grant 5,000 Ordinary Shares RSUs vesting in quarterly installments of 625 Ordinary Shares through December 18, 2027

Secondary RSU grant 528 Ordinary Shares RSUs vesting in quarterly installments of 66 Ordinary Shares through June 20, 2026

Stock option underlying shares 6 Ordinary Shares Underlying Ordinary Shares for the reported stock option (right to buy)

Option exercise price 31941.0000 Exercise price for the stock option expiring January 3, 2028

Option expiration date January 3, 2028 Expiration date of the reported stock option (right to buy)

Quarterly vesting installment (primary RSUs) 625 Ordinary Shares Size of each quarterly vesting installment for the 5,000-share RSU grant

Quarterly vesting installment (secondary RSUs) 66 Ordinary Shares Size of each quarterly vesting installment for the 528-share RSU grant

Key Terms

restricted share units ("RSUs"), Ordinary Shares, stock option (right to buy)

3 terms

restricted share units ("RSUs") financial

"Includes 5,000 ordinary shares ... issuable upon the vesting of restricted share units ("RSUs")"

Ordinary Shares financial

"5,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares")"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

stock option (right to buy) financial

"Stock option (right to buy) over 6.0000 underlying Ordinary Shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SciSparc (SPRC) disclose about the CTO’s share position in this Form 3/A amendment?

The amendment shows Chief Technology Officer Adi Zuloff-Shani has a reported position tied to 5,528 Ordinary Shares issuable upon RSU vesting and a stock option for 6 Ordinary Shares. It restates how these holdings are composed, without reporting any new transactions.

How are the 5,528 Ordinary Shares for SciSparc (SPRC) CTO Zuloff-Shani structured?

The 5,528 Ordinary Shares reflect RSUs, not already-issued stock: 5,000 Ordinary Shares from RSUs vesting in quarterly installments of 625 shares through December 18, 2027, and 528 Ordinary Shares from RSUs vesting 66 shares quarterly through June 20, 2026.

What RSU vesting schedules does SciSparc (SPRC) detail for its CTO in this filing?

SciSparc describes two RSU grants: one for 5,000 Ordinary Shares vesting in quarterly installments of 625 shares through December 18, 2027, and another for 528 Ordinary Shares vesting in quarterly installments of 66 shares through June 20, 2026. Each RSU delivers one Ordinary Share.

What stock option position is reported for the SciSparc (SPRC) CTO in this Form 3/A?

The filing restates an option described as a stock option (right to buy) over 6 Ordinary Shares with an exercise price of 31941.0000 and an expiration date of January 3, 2028. The option is held directly by the reporting person.

Does this SciSparc (SPRC) Form 3/A amendment report any insider buying or selling?

No buying or selling is reported. The entries are classified as holding records, and the transaction summary shows 0 buys, 0 sells and 2 holding entries, indicating the amendment only corrects and restates previously reported ownership details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 07:00 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zuloff-Shani Adi

(Last) (First) (Middle)

20 RAUL WALLENBERG STREET

TOWER A, TEL AVIV, ISRAEL

(Street)

TEL AVIV 6971916

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SciSparc Ltd. [ SPRC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	5,528(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	01/03/2022	01/03/2028	Ordinary Shares	6(2)	$31,941	D

Explanation of Responses:

1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends and restates the first footnote in Table I as follows: "Includes (i) 5,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 625 Ordinary Shares through December 18, 2027; and (ii) 528 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 66 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." In addition, this amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

	/s/ Adi Zuloff-Shani	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)